Caspofungin + Normal Saline
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Invasive Candidiasis
Conditions
Invasive Candidiasis
Trial Timeline
Aug 1, 2007 → Mar 1, 2010
NCT ID
NCT00520234About Caspofungin + Normal Saline
Caspofungin + Normal Saline is a approved stage product being developed by Merck for Invasive Candidiasis. The current trial status is completed. This product is registered under clinical trial identifier NCT00520234. Target conditions include Invasive Candidiasis.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00520234 | Approved | Completed |
Competing Products
20 competing products in Invasive Candidiasis